Asciminib (ABL001) CAS:1492952-76-7
Asciminib (ABL001) 
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-2199 | 50mg | 500.00 | + Add to cart  | 
																					|
| R-C-2199 | 100mg | 825.00 | + Add to cart  | 
																					|
| R-C-2199 | 200mg | 1350.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							Asciminib(ABL001)is a potent allosteric inhibitor of BCR-ABL.ABL001 prevents emergence of resistant disease when administered in combination with nilotinib in an in vivo murine model of chronic myeloid leukemia.Cell proliferation studies demonstrate that ABL001 selectively inhibited the growth of CML and Ph+ ALL cells with potencies ranging from 1-10nM range.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 2 years | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds--Asciminib (ABL001)  
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

